Phillips Wealth Planners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,120
Closed -$279K 213
2025
Q4
$279K Sell
5,120
-820
-14% -$39.4K 0.22% 156
2025
Q3
$268K Sell
5,940
-1,595
-21% -$74.5K 0.22% 157
2025
Q2
$354K Sell
7,535
-3,324
-31% -$163K 0.32% 106
2025
Q1
$551K Sell
10,859
-914
-8% -$53.3K 0.58% 54
2024
Q4
$657K Buy
11,773
+42
+0.4% +$2.35K 0.66% 43
2024
Q3
$626K Buy
11,731
+702
+6% +$32.9K 0.6% 47
2024
Q2
$454K Buy
11,029
+649
+6% +$29K 0.48% 73
2024
Q1
$501K Buy
10,380
+3,465
+50% +$177K 0.58% 52
2023
Q4
$346K Sell
6,915
-3,062
-31% -$161K 0.42% 84
2023
Q3
$564K Buy
9,977
+730
+8% +$44.7K 0.76% 40
2023
Q2
$591K Buy
9,247
+2,993
+48% +$201K 0.78% 43
2023
Q1
$428K Sell
6,254
-6
-0.1% -$423 0.57% 60
2022
Q4
$458K Buy
+6,260
New +$472K 0.8% 43

Other funds holding BMY

Phillips Wealth Planners's BMY Position: Q1 2026 in Review

Phillips Wealth Planners sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,120 shares — an estimated $279K sold.

Phillips Wealth Planners first reported a position in BMY in Q4 2022 and held it in 13 quarters. The position peaked at $657K in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Phillips Wealth Planners reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Phillips Wealth Planners sold 5,120 Bristol-Myers Squibb shares in Q1 2026, an estimated $279K.
  • Phillips Wealth Planners first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 13 quarters.
  • Phillips Wealth Planners's Bristol-Myers Squibb position peaked at $657K in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Phillips Wealth Planners's 13F filing for Q1 2026, filed 14 May 2026.